MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.550
-0.100 (-6.06%)
Oct 7, 2025, 4:00 PM EDT - Market closed
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $165.24 million as of October 7, 2025. Its market cap has decreased by -63.91% in one year.
Market Cap
165.24M
Enterprise Value
57.19M
1-Year Change
-63.91%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $165.24M, a decrease of -66.60%. That is a compound annual growth rate of -21.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 175.90M | -59.99% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
| Mar 10, 2021 | 494.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |